Šušnjar Stefan, Daniyal Ghauri Muhammad, Thomasson Björn, Konugolu Venkata Sekar Sanathana, Andersson-Engels Stefan, Swartling Johannes, Reistad Nina
Lund University, Department of Physics, Lund, Sweden.
SpectraCure AB, Lund, Sweden.
J Biomed Opt. 2025 Jan;30(1):015003. doi: 10.1117/1.JBO.30.1.015003. Epub 2025 Jan 30.
The spatial distribution of the photosensitizing drug concentration is an important parameter for predicting the photodynamic therapy (PDT) outcome. Current diffuse fluorescence tomography methods lack accuracy in quantifying drug concentration. The development of accurate methods for monitoring the temporal evolution of the drug distribution in tissue can advance the real-time light dosimetry in PDT of tumors, leading to better treatment outcomes.
We develop diffuse optical tomography methods based on interstitial fluorescence measurements to accurately reconstruct the spatial distribution of fluorescent photosensitizing drugs in real-time.
A two-stage reconstruction algorithm is proposed. The capabilities and limitations of this method are studied in various simulated scenarios. For the first time, experimental validation is conducted using the clinical system for interstitial PDT of prostate cancer on prostate tissue-mimicking phantoms with the photosensitizer verteporfin.
The average relative error of the reconstructed fluorophore absorption was less than 10%, whereas the fluorescent inclusion reconstructed volume relative error was less than 35%.
The proposed method can be used to monitor the temporal evolution of the photosensitizing drug concentration in tumor tissue during photodynamic therapy. This is an important step forward in the development of the next generation of real-time light dosimetry algorithms for photodynamic therapy.
光敏药物浓度的空间分布是预测光动力疗法(PDT)疗效的一个重要参数。当前的漫射荧光断层扫描方法在定量药物浓度方面缺乏准确性。开发用于监测组织中药物分布随时间演变的准确方法可以推动肿瘤光动力疗法中的实时光剂量测定,从而带来更好的治疗效果。
我们基于组织间荧光测量开发漫射光学断层扫描方法,以实时准确重建荧光光敏药物的空间分布。
提出一种两阶段重建算法。在各种模拟场景中研究了该方法的能力和局限性。首次使用前列腺癌组织间光动力疗法的临床系统,在含有光敏剂维替泊芬的前列腺组织模拟体模上进行了实验验证。
重建的荧光团吸收的平均相对误差小于10%,而荧光内含物重建体积相对误差小于35%。
所提出的方法可用于监测光动力疗法期间肿瘤组织中光敏药物浓度的时间演变。这是光动力疗法下一代实时光剂量测定算法开发中的重要一步。